⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
accessnewswire.com
VTGN
Pomerantz LLP Advises Shareholders of Class Action Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics Ready to Announce with Confidence?
newsfilecorp.com
VTGN
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
accessnewswire.com
VTGN
Pomerantz LLP Advises of Securities Class Action Involving Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
Bragar Eagel & Squire, P.C. Reminds Vistagen Therapeutics, Inc. Stockholders of the Upcoming Class Action Lead Plaintiff Deadline and Encourages Investors to Contact the Firm
globenewswire.com
VTGN
VTGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
VTGN
Pomerantz LLP Advises of Securities Class Action Involving Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - VTGN
prnewswire.com
VTGN
Shareholders that lost money on Vistagen Therapeutics, Inc.(VTGN) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
globenewswire.com
VTGN